dilluns, 8 de maig del 2017

Abbott lands French reimbursement win for FreeStyle Libre glucose monitor

Abbott FreeStyle LibreAbbott (NYSE:ABT) said today it won national reimbursement from the French Health ministry for its FreeStyle Libre wearable glucose monitor.

The FreeStyle Libre is designed to monitor glucose through a sensor worn on the back of the upper arm for 2 weeks, without the need for the finger prick calibration required by continuous glucose monitoring systems, the Abbott Park, Ill.-based company said.

Read the whole story on our sister site, Medical Design & Outsourcing

The post Abbott lands French reimbursement win for FreeStyle Libre glucose monitor appeared first on MassDevice.



from MassDevice http://ift.tt/2prPT8A

Cap comentari:

Publica un comentari a l'entrada